世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036237

腫瘍マーカー検査のヨーロッパ市場(2023〜2027年)- がん診断検査および分析装置の高成長機会 - フランス、ドイツ、イタリア、スペイン、イギリス - サプライヤーのシェアと戦略、主要腫瘍マーカーの検査量と売上セグメントの予測、最新技術と機器パイプライン、サプライヤーの新たな機会

VPGMarketResearch

2023-2027 Europe Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

発刊日 2023/09/25

言語英語

体裁PDF

ライセンス/価格

0000036237

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

この新しいレポートは、地域、国、市場セグメント、セクション、個々のマーカー別に入手でき、特定の情報ニーズや予算に合わせてカスタマイズすることが可能です。

このレポートは、診断業界の幹部や、ダイナミックで急速に拡大するがん診断検査市場への多角化を計画している企業が、今後 5 年間の新たな機会を評価し、効果的なビジネス戦略を開発するのに役立つように設計されています。

このレポートは、ヨーロッパの主要国の傾向を調査しています。現在および新たなアッセイのレビュー、新しい診断技術の潜在的な応用の分析、国および市場セグメントごとに主要な腫瘍マーカーの売上高の予測、主要なプレーヤーと潜在的な市場参入者のプロフィールの紹介、サプライヤーにとっての具体的なビジネスチャンスの特定を可能にします。

論理的根拠

研究者らが腫瘍の診断と治療における大きな技術的進歩に近づき、新たな特異抗原を発見し、病気の遺伝的基盤の謎を解明するにつれて、がん診断市場は爆発寸前となっています。今後 5 年間で、世界のがん診断市場は刺激的でダイナミックかつ急速に拡大する分野になることが予想されます。予想される技術的進歩により、遺伝的素因の決定、特定の腫瘍の検出、がん治療に対する生物学的反応のモニタリングのための多くの機会が生み出されるでしょう。高齢者人口の増加は、悪性腫瘍検査に対する需要の高まりと世界中での急速な市場の拡大をさらに複雑にするでしょう。

調査範囲

  • 調査国
    ➣ フランス
    ➣ ドイツ
    ➣ イタリア
    ➣ スペイン
    ➣ イギリス
  • ヨーロッパ市場の概要
    ➣ 国ごとの 5 年間の検査量と販売予測
    ➣ 国ごとの市場力学、構造、規模、成長、主要サプライヤーのレビューを含む、包括的な市場セグメンテーション分析
    ➣ がん診断検査を実施する研究所の推定対象国別の範囲
    ➣ がんの統計、病因、および最近の動向
  • ビジネスチャンスと戦略的提言
    ➣ 今後 5 年間に市場に大きな魅力をもたらす可能性がある特定の新製品開発の機会
    ➣ 新製品の設計基準
    ➣ 市場浸透のための代替戦略
    ➣ 潜在的な市場参入障壁とリスク
  • 200 を超える現在および新興のがん診断検査
    ➣ がん遺伝子
    ➣ 生化学マーカー
    ➣ 成長因子
    ➣ コロニー刺激因子
    ➣ ホルモン
    ➣ 免疫組織化学的染色
    ➣ リンホカイン
    ➣ ACTH、AFP、ベータ-2 ミクログロブリン、CA 15-3/27.29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異抗原、サイトケラチン、エストロゲン受容体、フェリチン、ガストリン、HCG、インスリン、インターフェロン、インターロイキン、リンパ球サブタイピング、ニューロン特異的エノラーゼ、核小体、潜血、がん遺伝子、膵臓癌胎児性抗原、パプスメア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸ホスファターゼ、前立腺特異抗原、S-100タンパク質、セロトニン、シアル酸、扁平上皮癌抗原、TDT、チミジンキナーゼ、チログロブリン、組織ポリペプチド抗原など
  • サプライヤーのシェア、売上高、検査量の予測
    ➣ 主要国の主要ながん診断製品サプライヤーの個別検査別の売上高および市場シェア
    ➣ 国および以下の市場セグメントごとの主要な腫瘍マーカーの 5 年間の検査量と売上予測
      ◇ 病院
      ◇ 商業/民間研究所
      ◇ 医師の診療所/グループ診療所
  • 機器のレビュー
    ➣ がん検査に使用される主要な分子診断および免疫診断分析装置の動作特性、機能、販売価格などの分析
  • 技術評価
    ➣ 最新の分子診断法、バイオチップ/マイクロアレイ、バイオセンサー、モノクローナル抗体、イムノアッセイ、染色体分析、IT、人工知能、フローサイトメトリー、その他の技術と癌診断検査への潜在的な応用の評価
    ➣ CT、MRI、NMR、PET、フォトニクス分光法などの競合/補完技術のレビュー。
    ➣ 新しいがん診断検査および検出技術を開発している企業、大学、研究センターの広範なリスト
  • 競争戦略
    ➣ 革新的ながん診断技術および製品を開発している主要なサプライヤーおよび新興企業の戦略的評価(販売、製品ポートフォリオ、マーケティング戦術、協力体制、研究開発における新製品など)
  • 調査企業
    ➣ Abbott
    ➣ Affymetrix
    ➣ Beckman Coulter/Danaher/Cepheid
    ➣ Becton Dickinson
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ DiaSorin
    ➣ 栄研化学(Eiken Chemical)
    ➣ Elitech Group
    ➣ Enzo Biochem
    ➣ 富士フイルム和光(Fujifilm Wako)
    ➣ 富士レビオ(Fujirebio)
    ➣ Grifols
    ➣ Hologic
    ➣ Leica Biosystems
    ➣ Perkin Elmer
    ➣ Qiagen
    ➣ QuidelOrtho
    ➣ Roche
    ➣ Siemens Healthineers
    ➣ タカラバイオ(Takara Bio)
    ➣ Thermo Fisher

レポート詳細

目次

Table of Contents

I. Introduction

II. Market Overview

III. Major Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Major Current and Emerging Cancer Diagnostic Tests
 1. Introduction
 2. Cancer Diagnostic Classification
 3. ACTH
 4. Alpha-Fetoprotein (AFP)
 5. Beta-2 Microglobulin
 6. CA 15-3/27.29
 7. CA 19-9
 8. CA-125
 9. Calcitonin
 10. Carcinoembrionic Antigen (CEA)
 11. Estrogen and Progesterone Receptors
 12. Ferritin
 13. Gastrin
 14. Human Chorionic Gonadotropin (HCG)
 15. Insulin
 16. NSE
 17. Occult Blood
 18. PAP Smear/HPV
 19. Prostatic Acid Phosphatase (PAP)
 20. Prostate-Specific Antigen (PSA)
 21. Squamous Cell Carcinoma Antigen (SCC)
 22. T and B Lymphocytes
 23. TdT
 24. Thyroglobulin
 25. Tissue Polypeptide Antigen (TPA)
 26. Biochemical Cancer Diagnostics
 27. Oncogenes
   - Abl/abl-bcr
   - AIB1
   - BCL-2
   - BRCA1
   - CD44
   - C-fos
   - C-myb
   - C-myc
   - CYP-17
   - Erb-B
   - HPC1
   - N-myc
   - P40
   - P51
   - P53
   - PIK3CA
   - PTI-1
   - Ras
   - Reg
   - Sis
   - Src and others
 28. Polypeptide Growth Factors
   - Basic Fibroblast Growth Factor
   - Beta-TGF
   - Cachectin (TNT)
   - Calmodulin
   - ECFR
   - Nerve Growth Factor (NGF)
   - Epidermal Growth Factor (EGF)
   - Ornithine Decarboxylase
   - Transferrin
   - Transforming Growth Factor-Alpha
 29. Ectopic Hormones
 30. Colony Stimulating Factors
 31. Lymphokines
   - Alpha-Interferon
   - B Cell Growth Factors
   - B Cell Growth Factor (BCGF)
   - Gamma-Interferon
   - Interleukin-1 (IL-1)
   - Macrophage Activating Factor
 32. Immunohistochemical Stains
 33. Emerging Cancer Diagnostics
   - N-Acetylglucosamine
   - Actin
   - Alpha-Actin
   - Antineuronal Antibodies
   - 7B2
   - B72.3
   - Bax
   - BCD-F9
   - BLCA-4
   - Blood Group Antigens A,B,H
   - CA 50
   - CA 72-4/TAG-72
   - CA 195
   - CA-242
   - CA-549
   - CAM 26
   - CAR-3
   - Cathepsin-D
   - Chromogranin A and B
   - Cluster 1 Antigen
   - Cluster-5/5A Antigen
   - CTA
   - CU18
   - DR-70
   - DU-PAN-2
   - Endometrial Bleeding Associated Factor
   - Endostatin
   - Epithelial Membrane Antigen
   - Feulgen Hydrolysis
   - Fibronectin
   - FSH
   - (1->3)-L-fucosyltransferase
   - Gastrin-Releasing Peptide (GRP)
   - GDCFP-15
   - Glucagon
   - Glycoamines
   - H23
   - Her-2
   - Human Carcinoma Antigen
   - HPA
   - HSP27
   - Intermediate Filaments
   - Cytokeratins/CK18/Cyfra 21-1
   - Desmin
   - Gliofibrillary Acid Protein
   - Neurofilaments
   - Vimentin
   - KA 93
   - Kinases
   - KP16D3
   - LAI
   - Leukocyte Common Antigen
   - Lewis Antigens
   - Lysophosphatidic Acid (LPA)
   - Ma 695/Ma 552
   - MABDF3
   - MAG
   - ME1
   - Minactivin
   - MN/CA9
   - MSA
   - Mucin Cancer Antigen (MCA)
   - Multiple Tumor Suppressor 1
   - Myosin
   - NEA-130
   - NMP22
   - OA-519
   - Opiod Peptides
   - P-glycoprotein
   - Pancreatic Oncofetal Antigen (POA)
   - Placental Lactogen
   - PR92
   - Proliferative Index, Ki-67
   - Px
   - RB Inactivation/Deletion
   - Ret
   - SCCL 175
   - Selectin
   - Sialic Acid
   - Sialyl SSEA-1/SLX
   - SN10
   - Somatostatin
   - TA-90
   - TABA
   - Tachykinin
   - TAG 12
   - TPS
   - Troponin
   - Tubulin
   - VCAM
   - VEGF
   - Villen and others

VIII. Instrumentation Review and Market Needs

IX. Current and Emerging Technologies
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 3. Molecular Diagnostics
 4. Chromosome Analysis
  a. Chronic Myelogenous Leukemia (CML)
  b. Acute Myeloid Leukemia (AML)
  c. Acute Lymphoblastic Leukemia (ALL)
  d. Malignant Lymphomas Lymphoid Malignancies
  e. Chronic Lymphocytic Leukemia (CLL)
  f. Solid Cancers
  g. Chromosomal Translocation and Oncogenes
 5. Artificial Intelligence
 6. Flow Cytometry
 7. Two Dimensional Gel Electrophoresis (2-DGE)
 8. Biosensors
 9. Competing/Complementing Technologies

X. Market Size, Test Volume and Sales Forecasts

XI. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
   - Abbott
   - Affymetrix
   - Beckman Coulter/Danaher/Cepheid
   - Becton Dickinson
   - bioMerieux
   - Bio-Rad
   - DiaSorin
   - Eiken Chemical
   - Elitech Group
   - Enzo Biochem
   - Fuifilm Wako
   - Fujirebio
   - Grifols
   - Hologic
   - Leica Biosystems
   - PerkinElmer
   - Qiagen
   - QuidelOrtho
   - Roche
   - Siemens Healthineers
   - Takara Bio
   - Thermo Fisher and others.

List of Tables
Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Ferritin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Gastrin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Interferons Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Interleukins Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market
Segment
France, Serotonin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market
Segment
France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales by Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Germany, Total
Tumor Marker Test Volume and Sales Forecast by Market Segment
Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales by Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment

Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Spain, Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume and Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier

この商品のレポートナンバー

0000036237

TOP